These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 28176132)

  • 1. Checking rounds for isolation precautions in the control of multidrug-resistant organisms: reduction achieved.
    Barbadoro P; Martini E; Gioia MG; Stoico R; Savini S; Manso E; Serafini G; Prospero E; D'Errico MM
    Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1105-1109. PubMed ID: 28176132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a Multicomponent Intervention to Reduce Multidrug-Resistant Organisms in Nursing Homes: A Cluster Randomized Clinical Trial.
    Mody L; Gontjes KJ; Cassone M; Gibson KE; Lansing BJ; Mantey J; Kabeto M; Galecki A; Min L
    JAMA Netw Open; 2021 Jul; 4(7):e2116555. PubMed ID: 34269807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the contribution of isolation precautions in prevention and control of multi-resistant bacteria in a teaching hospital.
    Eveillard M; Eb F; Tramier B; Schmit JL; Lescure FX; Biendo M; Canarelli B; Daoudi F; Laurans G; Rousseau F; Thomas D
    J Hosp Infect; 2001 Feb; 47(2):116-24. PubMed ID: 11170775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daily bathing strategies and cross-transmission of multidrug-resistant organisms: Impact of chlorhexidine-impregnated wipes in a multidrug-resistant gram-negative bacteria endemic intensive care unit.
    Ruiz J; Ramirez P; Villarreal E; Gordon M; Saez I; Rodríguez A; Castañeda MJ; Castellanos-Ortega Á
    Am J Infect Control; 2017 Oct; 45(10):1069-1073. PubMed ID: 28803661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cohorting to prevent acquisition of multidrug-resistant bacteria: An interrupted time series study.
    Arruda MC; de Aguiar RS; Jardim WM; Melo LH; Mendonça T; Cavalcanti AB; de França PHC
    Am J Infect Control; 2019 Feb; 47(2):180-185. PubMed ID: 30253905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection control procedures for extensively drug-resistant bacteria and related adverse effects: the experience at the Lyon University Hospitals from 2011 to 2017.
    Gerbier-Colomban S; Dananché C; Marion E; Bénet T; Dupieux C; Dauwalder O; Bryant J; Vanhems P
    Clin Microbiol Infect; 2019 Jul; 25(7):919-920. PubMed ID: 30797060
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of barrier precautions and surveillance cultures to control transmission of multidrug-resistant organisms: a systematic review of the literature.
    Aboelela SW; Saiman L; Stone P; Lowy FD; Quiros D; Larson E
    Am J Infect Control; 2006 Oct; 34(8):484-94. PubMed ID: 17015153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing multidrug-resistant organisms in home care and hospice: surveillance, prevention, and control.
    McGoldrick M; Rhinehart E
    Home Healthc Nurse; 2007 Oct; 25(9):580-6; quiz 587-8. PubMed ID: 18049254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bio-Kil, a nano-based disinfectant, reduces environmental bacterial burden and multidrug-resistant organisms in intensive care units.
    Lee WS; Hsieh TC; Shiau JC; Ou TY; Chen FL; Liu YH; Yen MY; Hsueh PR
    J Microbiol Immunol Infect; 2017 Oct; 50(5):737-746. PubMed ID: 27262208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrative review of infection prevention and control programs for multidrug-resistant organisms in acute care hospitals: a socio-ecological perspective.
    Backman C; Taylor G; Sales A; Marck PB
    Am J Infect Control; 2011 Jun; 39(5):368-378. PubMed ID: 21429622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative management of multidrug-resistant organisms in health care settings.
    Grota PG
    AORN J; 2007 Sep; 86(3):361-8; quiz 369-72. PubMed ID: 17822641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms.
    Passaretti CL; Otter JA; Reich NG; Myers J; Shepard J; Ross T; Carroll KC; Lipsett P; Perl TM
    Clin Infect Dis; 2013 Jan; 56(1):27-35. PubMed ID: 23042972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of electronic alerts on isolation precautions for patients with multidrug-resistant bacteria.
    Kac G; Grohs P; Durieux P; Trinquart L; Gueneret M; Rodi A; Boiron P; Guillemain R; Leglise J; Meyer G
    Arch Intern Med; 2007 Oct; 167(19):2086-90. PubMed ID: 17954803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation precautions for antibiotic-resistant bacteria in healthcare settings.
    Gasink LB; Brennan PJ
    Curr Opin Infect Dis; 2009 Aug; 22(4):339-44. PubMed ID: 19461513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations.
    Santos RP; Mayo TW; Siegel JD
    Clin Infect Dis; 2008 Jul; 47(1):110-6. PubMed ID: 18491966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infection control measures and prevalence of multidrug-resistant organisms in non-hospital care settings in northeastern Germany: results from a one-day point prevalence study.
    Hübner NO; Dittmann K; Begunk R; Kramer A;
    J Hosp Infect; 2017 Nov; 97(3):234-240. PubMed ID: 28797758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical distribution of multidrug-resistant bacteria (3537 isolates) in a tertiary Chinese hospital (January 2012-December 2013).
    Jia XQ; Pang F; Chen JZ; Jiang LX
    Pathol Biol (Paris); 2015 Feb; 63(1):21-3. PubMed ID: 25553645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of the automated risk assessment system for multidrug-resistant organisms (autoRAS-MDRO).
    Hur EY; Jin YJ; Jin TX; Lee SM
    J Hosp Infect; 2018 Feb; 98(2):202-211. PubMed ID: 28807836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact precautions in the intensive care unit setting: 12 years of surveillance.
    de Toledo Piza FM; Marra AR; Silva M; Sampaio Camargo TZ; de Oliveira Figueiredo RA; Edmond MB
    Am J Infect Control; 2013 Apr; 41(4):371-2. PubMed ID: 23062660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial of universal gloving with emollient-impregnated gloves to promote skin health and prevent the transmission of multidrug-resistant organisms in a surgical intensive care unit.
    Bearman G; Rosato AE; Duane TM; Elam K; Sanogo K; Haner C; Kazlova V; Edmond MB
    Infect Control Hosp Epidemiol; 2010 May; 31(5):491-7. PubMed ID: 20350197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.